Enter the first few characters of Company and click 'Go'
Audited Results of Bal Pharma Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
303.10 |
280.37 |
249.31 |
170.67 |
223.08 |
Manufacturing Expenses |
6.71 |
5.37 |
4.70 |
1.14 |
2.74 |
Personnel Expenses |
51.91 |
44.46 |
39.62 |
48.77 |
48.45 |
Selling Expenses |
2.90 |
2.22 |
1.41 |
3.19 |
2.62 |
Administrative Expenses |
45.16 |
38.35 |
26.43 |
26.28 |
31.73 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
277.07 |
257.16 |
222.99 |
163.92 |
202.77 |
Operating Profit |
26.03 |
23.20 |
26.32 |
6.75 |
20.31 |
Other Recurring Income |
2.15 |
6.49 |
2.69 |
3.62 |
2.75 |
Adjusted PBDIT |
28.19 |
29.69 |
29.01 |
10.37 |
23.05 |
Financial Expenses |
12.16 |
10.40 |
11.96 |
12.42 |
12.53 |
Depreciation |
7.48 |
7.24 |
7.26 |
7.03 |
6.12 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
8.55 |
12.06 |
9.80 |
-9.08 |
4.41 |
Tax Charges |
2.42 |
3.48 |
0.70 |
-0.17 |
-2.35 |
Adjusted PAT |
6.13 |
8.58 |
9.10 |
-8.90 |
6.76 |
Non Recurring Items |
0 |
0 |
0 |
0 |
0 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
6.13 |
8.58 |
9.10 |
-8.90 |
6.76 |
Equity Dividend |
1.56 |
1.48 |
0 |
1.13 |
1.71 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
46.94 |
42.37 |
35.27 |
26.47 |
36.79 |